Navigation Links
Rigel Announces First Quarter Financial Results
Date:5/3/2011

are delighted by the progress AstraZeneca has made with the fostamatinib phase 3 program," said James M. Gower, chairman and chief executive officer of Rigel. "We currently expect to begin two phase 1 clinical trials with our internal JAK3 programs by the end of 2011. The first is a novel oral JAK3 inhibitor intended for the treatment of transplant rejection and the second is a different JAK3 inhibitor in a topical formulation intended for the treatment of discoid lupus," he added.

About Rigel (www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its phase 3 clinical trial program for rheumatoid arthritis, and R343, an inhaled syk inhibitor that has completed Phase 1 clinical trials for asthma.

This press release contains "forward-looking" statements, including, without limitation, statements related to Rigel's expectations as to its year-end cash position and the sufficiency of its cash, cash equivalents and available for sale securities; and identification of a novel programs for clinical development, the potential indications for treatment, and the timing of clinical trials with respect thereto.  Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as " "intend," "expect," and similar expressions are intended to identify these forward-looking statements. These forward-looking statement
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
2. Rigel to Present at Three Upcoming Investor Conferences
3. Rigel Announces Participation at Two Investor Conferences
4. Rigel to Present at JP Morgan Healthcare Conference
5. Rigel Announces Third Quarter 2009 Financial Results
6. Rigel Announces Presentations at Two Investor Conferences
7. Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
8. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
9. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
10. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
11. Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 18, 2014   Aratana Therapeutics, Inc ... company focused on the licensing, development and commercialization ... positive results from its pivotal field study of ... pain in dogs with osteoarthritis.  In the study, ... scores that were statistically significant compared to placebo ...
(Date:12/19/2014)... development with the growth pace keeping at 20%-30% in last ... size of China separating membrane products ... 16.3%. It is projected that China ... 20% in the upcoming years and that the figure by ... integrated membrane industrial system has taken shape in ...
(Date:12/17/2014)... Los beneficios y ganancias están ... de gasto en investigación y desarrollo   ... de septiembre de 2014) ZEISS aumentó sus ingresos en ... (año anterior: 4.190 millones de euros) a pesar de ... crecieron un 14 por ciento, a 360 millones de ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3ZEISS confirma su posición en un entorno difícil 2
(Date:12/20/2014)... MissyDress, a distinguished special dress supplier, ... The business has drastically cut prices to all its ... until Jan. 30, 2015. Many of the hottest styles ... dresses, lace dresses, and more. , A spokesman for ... day. Whether A-line princess prom dresses or sweetheart chiffon ...
(Date:12/20/2014)... York, NY (PRWEB) December 20, 2014 ... that allege a metal-on-metal version of the artificial ... forward in state and federal courts, Bernstein Liebhard ... New Jersey’ Bergen County Superior Court on December ... permitted to begin deposition of plaintiffs on November ...
(Date:12/20/2014)... The Doctor’s Office Urgent Care of Paramus, New ... a decade. They’ve treated over 40,000 patients while carrying ... alternative to the Paramus area. , For 2015, ... their staff of top-notch board certified physicians: Christine Milosis MD, ... These new doctors will work tirelessly to carry out The ...
(Date:12/20/2014)... NY (PRWEB) December 20, 2014 The aftermath ... caused quite a stir, not only in Hollywood, but worldwide. ... December 18th , the ripples of that attack are starting ... very jobs at risk. But they are not the ... exposed could be in for some embarrassing times ahead, agents ...
(Date:12/20/2014)... The Twin Cities DI Day is recognized as the ... 250 financial professionals come together each year to hear ... motivated to protect their clients and to be inspired ... challenges of disability. , On September 23rd, 2014, financial ... attend The 13th Annual Twin Cities DI Day where ...
Breaking Medicine News(10 mins):Health News:MissyDress: The Prices of Prom Dresses Just Reduced 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4Health News:The Doctor's Office Urgent Care Adds 3 New Physicians to Their Growing Medical Team 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 2Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 3Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 4Health News:Sony Pictures Hack Perfect Example of the Reach a Single Cyber Attack Can Have 5Health News:The 13th Annual Twin Cities DI Day Now On Video 2Health News:The 13th Annual Twin Cities DI Day Now On Video 3
... order prescription drugs through the mail may not be ... ,In recent years, mail-order pharmacies, owned by pharmacy-benefit ... prescription benefits to their employees. Their belief – supported ... is that, overall, drugs purchased by mail cost a ...
... Guiliano’s bestseller ‘French Women Don’t Get Fat’ may need a ... 63.4 million// people are obese and 20 million are overweight. ... their heads for effective ways to come back to the ... , Something they are doing now is coming down hard ...
... in Britain have come under a scanner due to ... of the American Medical Association. ,According to ... period may actually increase the mortality rate by 5% ... conceiving in women. The researchers from Copenhagen University Hospital ...
... deals given by pay review bodies of the government will ... sector workers across the country//. ,The announcements have ... ,Health Secretary Patricia Hewitt has announced that GPs or ... profits for them had soared to more than 50 percent ...
... spring in several parts of the world, while the temperature ... is infamous for a strange 'fever', characterized by sweaty palms ... school- and college–going children. Yes, it is that time of ... competence, along with parental senility, is put to ...
... signed a landmark cooperative treaty here Thursday to set ... practitioners to help in the fight against AIDS and ... academic and clinical TCM research, setting new standards for ... developing new TCM products, said the document signed by ...
Cached Medicine News:Health News:Mail-Order Drugs: Deal or No Deal? 2Health News:UK’s Health Services Totterin 2Health News:Busting the Exam Blues 2Health News:Busting the Exam Blues 3Health News:Busting the Exam Blues 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: